Helius Medical Technologies, Inc. provided revenue guidance for the first quarter of 2022. For the period, the company expects revenue to range from $150,000 to $170,000 and quarterly revenue to increase sequentially each quarter throughout the year as the U.S. commercialization of PoNS develops.
Helius Medical Technologies, Inc.
Equities
HSDT
US42328V8019
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -8.78% | -17.62% | -82.71% |
05-13 | Transcript : Helius Medical Technologies, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
05-13 | Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Posts Q1 Revenue $135,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-82.71% | 5.54M | |
+11.80% | 227B | |
+15.53% | 197B | |
+18.63% | 141B | |
+30.06% | 110B | |
+0.65% | 64.15B | |
+17.38% | 53.72B | |
+5.82% | 51.75B | |
+11.16% | 45.2B | |
+5.69% | 37.37B |
- Stock Market
- Equities
- HSDT Stock
- News Helius Medical Technologies, Inc.
- Helius Medical Technologies, Inc. Provides Revenue Guidance for the First Quarter of 2022